Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced MelanomaMiguel‐Angel Perales, Jedd D. Wolchok, Teresa Rasalan et al.|Molecular Therapy|2008Cited by 100
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.Jianda Yuan, Jedd D. Wolchok, Geoffrey Y. Ku et al.|PubMed|2009Cited by 80